The conversion in application of percutaneous coronary intervention following the introduction of drug eluting stents.
In order to determine the changes in the pattern of techniques applied during elective coronary intervention, data from 688 patients prior to Sirolimus. Drug-Eluting Stents (DES) approval was compared to 438 patients who underwent coronary intervention after DES approval. There was increased intervention to higher risk lesions, including smaller vessels and re-stenotic lesions after DES approval. Total number of stents per patient significantly decreased, despite longer stent length per patient or per lesion after DES approval. No significant difference was found in multivessel interventions.
Ikeno
Fumiaki
F
Raissi Shabari
Farshad
F
Sadoughi
Ali
A
Lyons
Jennifer K
JK
Pourdehmobed
Kourosh
K
Hashemi
Vahideh
V
Emami
Sacha
S
Kaneda
Hideaki
H
Kanada
Hideaki
H
Yeung
Alan C
AC
Rezaee
Mehrdad
M
D000368:Aged; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000517:prevention & control; D023921:Coronary Stenosis / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D015607:Stents; D016896:Treatment Outcome
D020099:Coated Materials, Biocompatible